LNC Therapeutics
LNC Therapeutics develops gut microbiota directed drugs and medical nutrition products to treat obesity and associated cardiometabolic diseases. Their pipeline includes the TEMYS project for drug development and STABLOR, a medical nutrition product. The company targets patients, healthcare professionals, and pharmaceutical groups to address metabolic disorders through microbiome research.
Visit websiteBordeaux, France
Biotech
Healthcare
Metabolic Health
Funding summary
- Total raised
- €6.5M
- Funding rounds
- 1
Investors in LNC Therapeutics
Investors on record for LNC Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like LNC Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors